Cytotoxic T lymphocyte responses against melanocytes and melanoma

被引:0
作者
Gwendolen Y Chang
Holbrook E Kohrt
Tor B Stuge
Erich J Schwartz
Jeffrey S Weber
Peter P Lee
机构
[1] Stanford University School of Medicine,Department of Medicine, Division of Hematology
[2] Stanford University School of Medicine,Department of Pathology
[3] Moffitt Cancer Center,undefined
来源
Journal of Translational Medicine | / 9卷
关键词
Melanoma; Melanoma Cell; Ipilimumab; Vitiligo; Normal Melanocyte;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 305 条
[1]  
Hodi FS(2010)Improved survival with ipilimumab in patients with metastatic melanoma N Engl J Med 363 711-723
[2]  
O'Day SJ(2008)Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens J Clin Oncol 26 5233-5239
[3]  
McDermott DF(2000)Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo J Exp Med 192 1637-1644
[4]  
Weber RW(2005)Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity? Pigment Cell Res 18 234-242
[5]  
Sosman JA(2003)Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin? Pigment Cell Res 16 254-260
[6]  
Haanen JB(2008)Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity Proc Natl Acad Sci USA 105 8061-8066
[7]  
Gonzalez R(2011)Autoimmunity and treatment outcome in melanoma Curr Opin Oncol 23 170-176
[8]  
Robert C(1996)Identification of the genes encoding cancer antigens: implications for cancer immunotherapy Adv Cancer Res 70 145-177
[9]  
Schadendorf D(1993)Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy Int J Cancer 54 177-180
[10]  
Hassel JC(1998)The use of melanosomal proteins in the immunotherapy of melanoma J Immunother 21 237-246